Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: Coincidence or comorbidity?

Pediatric Obesity

Volumn 9, Issue 5, 2014, Pages e99-e102

  Nobili, V ^a   Alisi, A ^a   Grimaldi, C ^a   Liccardo, D ^a   Francalanci, P ^a   Monti, L ^a   Castellano, A ^a   De Ville De Goyet, J ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Hepatocellular carcinoma; Non alcoholic fatty liver disease; Obesity; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BEVACIZUMAB; CHOLESTEROL; CISPLATIN; DOXORUBICIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CASE REPORT; CHILD; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; COMPUTED TOMOGRAPHY SCANNER; DIET THERAPY; DISEASE ASSOCIATION; FERRITIN BLOOD LEVEL; FEVER; GASTROINTESTINAL ENDOSCOPY; GLUCOSE BLOOD LEVEL; HEADACHE; HEMATEMESIS; HEMOGLOBIN BLOOD LEVEL; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE CYCLE TREATMENT; NONALCOHOLIC FATTY LIVER; NUCLEAR SIZE; OBESITY; OESOPHAGOGASTROSCOPY; POSTPRANDIAL VOMITING; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; VOMITING; WAIST CIRCUMFERENCE; BIOPSY; BODY MASS; CARCINOMA, HEPATOCELLULAR; COMPLICATION; LIVER; LIVER NEOPLASMS; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PEDIATRIC OBESITY; TREATMENT OUTCOME; WEIGHT REDUCTION;

BIOPSY; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; CHILD; COMORBIDITY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PEDIATRIC OBESITY; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84908031482     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/j.2047-6310.2013.00209.x     Document Type: Article

References (12)

1. Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P. 360-degree overview of paediatric NAFLD: recent insights. J Hepatol 2013; 58: 1218-1229.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
3. Paradis V, Zalinski S, Chelbi E, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009; 49: 851-859.
4. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007; 97: 1005-1008.
5. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012; 56: 1384-1391.
6. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972-1978.
7. White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012; 10: 1342-1359.
8. Czauderna P, Mackinlay G, Perilongo G, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 2002; 20: 2798-2804.
9. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
10. Kawada N, Imanaka K, Kawaguchi T, et al. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol 2009; 44: 1190-1194.
11. Torres DM, Harrison SA. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. Semin Liver Dis 2012; 32: 30-38.
12. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943.